Cambridge start-up Lucida Medical gains CE mark for AI software that aids accurate prostate cancer diagnosis
It will be available in the UK and Europe in the first quarter of 2024.
Source: cambridgeindependent.co.uk
Stay updated with breaking news from Prostate Intelligence. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It will be available in the UK and Europe in the first quarter of 2024.
Lucida Medical receives CE marking for Pi, its AI-machine learning software for detecting prostate cancer from MRI, enabling faster and more accurate prostate cancer detectionCambridge, UK – 1st June 2021: Lucida Medical Ltd, the Cambridge, UK based start-up, has completed CE marking for its new machine learni...